RCE recce pharmaceuticals ltd

3.33%

31.0¢

Why are you losing sleep over not getting more at 68c...? Sounds...

First 20 Last

Share
Profile

Follow
The Ace

9,997 Posts.

59

13/07/20

09:35

Post #: 45816343
Share

Originally posted by Bpharma: ↑

thanks for that
good to see vesty super increasing the holding as the share price appreciated rather the sell down
boy the free float is going to make it hard for an insto to get on board before phase three if at most they only need circa $10 m for phase 2
if the cap raise is spread a bit 5 of them would likely get less than 2$ mill ea
i expect some to be forced to enter the market soon
collins st fund managers said they entered par early phase 2 ( unusually for them) as the evidence for success exhibited by tga special access trials was overwhelming efficacy
its hard for recce to be accessed via similar GP tga application as its a hospital iv application to v sick sepsis patients and hospitals very very reluctant to use non fda approved drugs for even life critical situations
so apart from upcoming possible covid CSIRO tests in vivo in vitro etc in non humans, we need to look elsewhere for such confirmation
all pre clinical bacteria and virus tests have exhibited exceptionsl efficacy and no toxic indications even at 10 - 100 times expected efficacy dosages
tests on humans for taking preclinical gonnoreha tests are likely to be a lot faster to gain approval for use
same with outstanding results on urinary tract infections
all serious concerns over bacterial resistance to current penecillin based drugs
the first up for human use is i reckon human trials in burn and other open skin wound exposures where rec327 has shown superior non toxic performance in mice etc
all these parameters going on concurrently provide a very rich news agenda over this year and next
at this mc under $300 m i reckon a major undervalued risk valuation is still priced into the market
after reading in detail the recent imu presentation for investors on values applied to small - mid cap bio pharma- to big big cap pharma
$350 seems the lower bar $1.5 the upper for where recce is right now
if one realistically applies the depth of the market on all these possible unmet medical issues from which millions are dying the numbers are truly extraordinary !
even a 10 pct penetration like collins st fund managers applied to PAR results in a multi bill valuation
if recce becomes a first in line defense as they say they exoect would be appropriate to eventuAte those numbers look clearly conservative
the recent year/months revaluation trajectory is i very much believe just the start of an exponential rise in value
but then i ve been saying this since 14c and 26 c
now im really really saying it louder
yes im a big investor and looking for more
i lose sleep over not getting more at 68c recently as others but that miss is tiny to the gain ahead i feel sure
cheers as always

Expand

Why are you losing sleep over not getting more at 68c...? Sounds like you loaded up big time in the 20's and 30's. It can still go pear shaped you know. It might be wise to truncate your emotions from this stock.

RCE Price at posting: $1.05 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 20 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 31.0¢		Change 0.010(3.33%)		Mkt cap ! $89.39M

Open	High	Low	Value	Volume
31.0¢	32.0¢	30.0¢	$25.76K	82.29K

Buyers (Bids)

No.	Vol.	Price($)
2	13550	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
31.0¢	18938	1

View Market Depth

No.	Vol.	Price($)
2	13550	0.300
2	34803	0.295
2	50000	0.290
4	131061	0.285
10	251389	0.280

Price($)	Vol.	No.
0.310	18938	1
0.320	5000	1
0.325	12600	1
0.330	114230	1
0.350	51319	4

Last trade - 16.10pm 27/06/2025 (20 minute delay)

RCE (ASX) Chart

Why are you losing sleep over not getting more at 68c...? Sounds...

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why are you losing sleep over not getting more at 68c...? Sounds...

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News